跳至主要内容
临床试验/NCT05962255
NCT05962255已完成3 期

The Impact of Slow, Continuous Infusion of Sodium Chloride or Glucose Solution on Diuresis and Urine Composition During Decongestion of Acute Heart Failure Patients

Wroclaw Medical University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Urine volume change at individual timepoints during second day of the procedure.

研究概览

简要总结

The aim of the study is to compare the differences in diuretic, natriuretic and clinical response to decongestion in patients receiving different replacement fluid regimens (0.9% sodium chloride vs 5% glucose) in acute heart failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients >18 years old who sign the informed consent
  • the primary cause of hospitalization is Acute Heart Failure with a need for intravenous Furosemide
  • the start of the study within 24h of hospital admission

排除标准

  • need for inotropic support
  • end stage renal disease on dialysis
  • serum sodium > 148mmol/l or < 130 mmol/l.

研究组 & 干预措施

0.9 % Sodium Chloride solution

Experimental

Patients receiving an intravenous infusion of 0.9% NaCl

干预措施: Furosemide intravenous infusion (Drug)

0.9 % Sodium Chloride solution

Experimental

Patients receiving an intravenous infusion of 0.9% NaCl

干预措施: Continous intravenous infusion of 0.9% Sodium Chloride solution (Drug)

5% Glucose solution

Active Comparator

Patients receiving an intravenous infusion of 5% glucose

干预措施: Furosemide intravenous infusion (Drug)

5% Glucose solution

Active Comparator

Patients receiving an intravenous infusion of 5% glucose

干预措施: Continous intravenous infusion of 5% Glucose solution (Drug)

结局指标

主要结局

Urine volume change at individual timepoints during second day of the procedure.

时间窗: 48 hours

Comparison of urine volume between the groups at individual timepoints during the second day of the procedure.

Urine volume change at individual timepoints during first day of the procedure.

时间窗: 24 hours

Comparison of urine volume between the groups at individual timepoints during the first day of the procedure.

Total dose of furosemide.

时间窗: 48 hours

Comparison of the total dose of furosemide between the groups at hours.

Urine composition at individual time points.

时间窗: 72 hours

Comparison of urine composition (urinary sodium and urinary chloride) between the groups and its change during 72h

Cumulative urine output at 24 hours.

时间窗: 24 hours

Comparison of cumulative urine output between the groups at 24 hours.

Cumulative urine output at hours.

时间窗: 48 hours

Comparison of cumulative urine output between the groups at 48 hours.

次要结局

  • Total time on intravenous furosemide.(3 months)
  • Renin-Angiotensin-Aldosterone system activity.(48 hours)
  • Heart Failure rehospitalization(30 days)

研究者

发起方
Wroclaw Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gracjan Iwanek

Medical Doctor

Wroclaw Medical University

研究点 (1)

Loading locations...

相似试验

Sodium Chloride vs. Glucose Solute as a Volume... | 临床试验